This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hooper, N. M. Articles by Turner, A. J. Search for Related Content PubMed PubMed Citation Articles by Hooper, N. M. Articles by Turner, A. J.

Hypertension, Vol 19, 281-285, Copyright © 1992 by American Heart Association

ARTICLES

Inhibition by converting enzyme inhibitors of pig kidney aminopeptidase P

NM Hooper, J Hryszko, SY Oppong and AJ Turner
Department of Biochemistry and Molecular Biology, University of Leeds, UK.

Several inhibitors of angiotensin converting enzyme were also found to inhibit aminopeptidase P, whereas inhibitors of other mammalian aminopeptidases were ineffective. Aminopeptidase P purified from pig kidney cortex was found to contain one atom of zinc per polypeptide chain, confirming its metalloenzyme nature. The concentrations of converting enzyme inhibitors required to cause 50% inhibition (I50) of aminopeptidase P were in the low micromolar range. The most potent converting enzyme inhibitors toward aminopeptidase P were the carboxylalkyl compounds, cilazaprilat, enalaprilat, and ramiprilat (I50 values of 3-12 microM). The sulfhydryl compounds captopril (I50 110 microM) and YS980 (I50 20 microM) were slightly less potent at inhibiting aminopeptidase P. In contrast, the carboxylalkyl compounds benazeprilat, lisinopril, and pentoprilat; the sulfhydryl compound rentiapril; and the phosphoryl compounds ceranopril and fosinoprilat had no inhibitory effect against aminopeptidase P. This compares with I50 values in the 1-6 nM range for these inhibitors with angiotensin converting enzyme. Inhibition of aminopeptidase P may account for some of the effects or side effects noted with the clinical use of converting enzyme inhibitors. These results may provide the basis for the design of more selective inhibitors of angiotensin converting enzyme or mixed inhibitors of aminopeptidase P and angiotensin converting enzyme, or both.

This article has been cited by other articles:

				D. Ragheb, K. Bompiani, S. Dalal, and M. Klemba Evidence for Catalytic Roles for Plasmodium falciparum Aminopeptidase P in the Food Vacuole and Cytosol J. Biol. Chem., September 11, 2009; 284(37): 24806 - 24815. [Abstract] [Full Text] [PDF]

				S. C. Chai, W.-L. Wang, and Q.-Z. Ye FE(II) Is the Native Cofactor for Escherichia coli Methionine Aminopeptidase J. Biol. Chem., October 3, 2008; 283(40): 26879 - 26885. [Abstract] [Full Text] [PDF]

				Q.-Z. Ye, S.-X. Xie, Z.-Q. Ma, M. Huang, and R. P. Hanzlik Structural basis of catalysis by monometalated methionine aminopeptidase PNAS, June 20, 2006; 103(25): 9470 - 9475. [Abstract] [Full Text] [PDF]

				M. E. Moreau, P. Dubreuil, G. Molinaro, M. Chagnon, W. Muller-Esterl, Y. Lepage, F. Marceau, and A. Adam Expression of Metallopeptidases and Kinin Receptors in Swine Oropharyngeal Tissues: Effects of Angiotensin I-Converting Enzyme Inhibition and Inflammation J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1065 - 1074. [Abstract] [Full Text] [PDF]

				U. Hilbers, J. Peters, S. R. Bornstein, F. M. A. Correa, O. Johren, J. M. Saavedra, and M. Ehrhart-Bornstein Local Renin-Angiotensin System Is Involved in K+-Induced Aldosterone Secretion from Human Adrenocortical NCI-H295 Cells Hypertension, April 1, 1999; 33(4): 1025 - 1030. [Abstract] [Full Text] [PDF]

				R. D. Paula, C. V. Lima, M. C. Khosla, and R. A.S. Santos Angiotensin-(1-7) Potentiates the Hypotensive Effect of Bradykinin in Conscious Rats Hypertension, December 1, 1995; 26(6): 1154 - 1159. [Abstract] [Full Text]

				J. C. Hartman The Role of Bradykinin and Nitric Oxide in the Cardioprotective Action of ACE Inhibitors Ann. Thorac. Surg., September 1, 1995; 60(3): 789 - 792. [Abstract] [Full Text]